A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease

Biochemical and Biophysical Research Communications

Volumn 459, Issue 3, 2015, Pages 361-366

  Xie, Bingjie ^a   Lin, Fankai ^a   Ullah, Kaleem ^a   Peng, Lei ^a   Ding, Wei ^a   Dai, Rongji ^a   Qing, Hong ^a   Deng, Yulin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

1 Acetyl 6 7 dihydroxyl 1 2 3 4 tetrahydroisoquinoline (ADTIQ); Diabetes; Methylglyoxal; Parkinson's disease (PD)

Indexed keywords

1-ACETYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE; ALPHA SYNUCLEIN; GLUCOSE; METHYLGLYOXAL; MUTANT PROTEIN; NEUROTOXIN; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL; BRAIN; CELL DEATH; CELL LINE; CHEMISTRY; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; HYPERGLYCEMIA; METABOLISM; MOUSE; PARKINSON DISEASE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; CELL DEATH; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINERGIC NEURONS; GLUCOSE; HUMANS; HYPERGLYCEMIA; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; NEUROTOXINS; PARKINSON DISEASE; PYRUVALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES;

EID: 84931331883     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.069     Document Type: Article

References (34)

1. B.S. Shastry Parkinson disease: etiology, pathogenesis and future of gene therapy J. Neurosci. Res. 41 2001 5 12
2. T.N. Chase, J.D. Oh, and P.J. Blanchet Neostriatal mechanisms in Parkinson's disease J. Neurol. 51 1998 S30 S35
3. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 J. Diabetes Care 27 2004 1047 1053
4. A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, R. Freeman, R.A. Malik, R.E. Maser, J.M. Sosenko, and D. Ziegler Diabetic neuropathies: a statement by the American Diabetes Association J. Diabetes Care 28 2005 956 962
5. G. Hu, P. Jousilahti, S. Bidel, R. Antikainen, and J. Tuomilehto Type 2 diabetes and the risk of Parkinson's disease J. Diabetes Care 30 2007 842 847
6. J.A. Driver, A. Smith, J.E. Buring, J.M. Gaziano, T. Kurth, and G. Logroscino Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease J. Diabetes Care 31 2008 2003 2005
7. Q. Xu, Y. Park, X. Huang, A. Hollenbeck, A. Blair, A. Schatzkin, and H. Chen Diabetes and risk of Parkinson's disease J. Diabetes Care 34 2011 910 915
8. Y. Deng, Y. Zhang, Y. Li, S. Xiao, D. Song, H. Qing, Q. Li, and A.H. Rajput Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains J. Neural Transm. 119 2012 435 441
9. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis J. Sci. 219 1983 979 980
10. A.H. Rajput Environmental toxins accelerate Parkinson's disease onset J. Neurol. 56 2001 4 5
11. D.A. Di Monte The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? J. Lancet Neurol. 2 2003 531 538
12. Y. Deng, Y. Luan, H. Qing, H. Xie, J. Lu, and J. Zhou The formation of catechol isoquinolines in PC12 cells exposed to manganese J. Neurosci. Lett. 444 2008 122 126
13. M. Naoi, W. Maruyama, K. Matsubara, and Y. Hashizume A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains J. Neurosci. Lett. 235 1997 81 84
14. W. Maruyama, T. Abe, H. Tohgi, P. Dostert, and M. Naoi A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid J. Annals neurol. 40 1996 119 122
15. M. Naoi, W. Maruyama, P. Dostert, K. Kohda, and T. Kaiya A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol J. Neurosci. Lett. 212 1996 183 186
16. D.W. Miller, S.M. Hague, J. Clarimon, M. Baptista, K. Gwinn-Hardy, M.R. Cookson, and A.B. Singleton Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication J. Neurol. 62 2004 1835 1838
17. K.A. Conway, J.D. Harper, and P.T. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease J. Nat. Med. 4 1998 1318 1320
18. B. Mravec Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments J. Physiol. Res. 55 2006 353 364
19. S. Kikuchi, K. Shinpo, F. Moriwaka, Z. Makita, T. Miyata, and K. Tashiro Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases J. Neurosci. Res. 57 1999 280 289
20. K. Shinpo, S. Kikuchi, H. Sasaki, A. Ogata, F. Moriwaka, and K. Tashiro Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons J. Brain Res. 861 2000 151 159
21. Z. Turk, I. Nemet, L. Varga-Defteardarovic, and N. Car Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase J. Diabetes Metab. 32 2006 176 180
22. J. Lu, E. Randell, Y. Han, K. Adeli, J. Krahn, and Q.H. Meng Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy J. Clin. Biochem. 44 2011 307 311
23. D.L. Vander Jagt Methylglyoxal, diabetes mellitus and diabetic complications J. Drug Metabol. Drug Interact. 23 2008 93 124
24. B. Xie, Y. Xiong, K. Ullah, L. Peng, F. Lin, Z. Zhang, H. Qing, and Y. Deng Determination of endogenous neurotoxin 1-Acetyl-6,7-Dihydroxyl-1,2,3,4-Tetrahydroisoquinoline in rat substantia nigra by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry J. Anal. Lett. 46 2013 2828 2834
25. M. Farrer, J. Kachergus, L. Forno, S. Lincoln, D.S. Wang, M. Hulihan, D. Maraganore, K. Gwinn-Hardy, Z. Wszolek, D. Dickson, and J.W. Langston Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications J. Ann. Neurol. 55 2004 174 179
26. W. Maruyama, P. Dostert, K. Matsubara, and M. Naoi N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity J. Free Radic. Biol. Med. 19 1995 67 75
27. A. Storch, A. Kaftan, K. Burkhardt, and J. Schwarz 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism J. Brain Res. 855 2000 67 75
28. G.A. Smythe, and M.W. Duncan Precise GC/MS assays for salsolinol and tetrahydropapaveroline: the question of artifacts and dietary sources and the influence of alcohol J. Prog. Clin. Biol. Res. 183 1985 77 84
29. X. Chen, Y. Chen, G. Wu, J. Lu, J. Iqbal, H. Qing, and Y. Deng Existence and characterization of salsolinol synthase in neuronal cells and rat brain J. Neurochemical 7 2013 192 197
30. W. Maruyama, D. Nakahara, M. Ota, T. Takahashi, A. Takahashi, T. Nagatsu, and M. Naoi N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study J. Neurochem. 59 1992 395 400
31. R. Wang, H. Qing, X.Q. Liu, X.L. Zheng, and Y.L. Deng Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells J. Neurosci. Bull. 24 2008 125 132
32. Y. Zhang, J. Zhang, Y. Deng, C. Tian, X. Li, J. Huang, and H. Fan Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis J. Cancer 117 2011 4312 4324
33. P.E. Morgan, R.T. Dean, and M.J. Davies Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products J. Arch. Biochem. Biophys. 403 2002 259 269
34. S.G. de Arriba, G. Stuchbury, J. Yarin, J. Burnell, C. Loske, and G. Munch Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers J. Neurobiol. Aging 28 2007 1044 1050